Fundz

Scottish Startup Microplate Dx Secures £2.5M To Reduce Deaths Caused By Drug-Resistant Infections

PRIVATESep 11, 2023

Amount Raised

£2.5 Million

Round Type

Seed

GlasgowBiotechnology

Investors

Thairm BioSIS VenturesScottish EnterpriseThe University Of StrathclydeDeepbridge Capital LLP

Description

Now, the Glasgow diagnostics spinout Microplate Dx has closed a £2.5 million seed funding round to develop its point-of-care diagnostic platform. The funding came from existing investors, including Deepbridge Capital LLP and the University of Strathclyde alongside new investors Scottish Enterprise (which backed BDD and SOLASTA Bio), impact investor SIS Ventures, and Boston-based life sciences investor Thairm Bio. 

Quick answer

Microplate Dx raised £2.5 Million in a Seed round, dated September 11, 2023. Investors: Thairm Bio, SIS Ventures, Scottish Enterprise, The University Of Strathclyde and Deepbridge Capital LLP. Microplate Dx is based in Glasgow, Scotland, United Kingdom.

How much did Microplate Dx raise?
Microplate Dx raised £2.5 Million in a Seed round on September 11, 2023.
Who invested in Microplate Dx?
Thairm Bio, SIS Ventures, Scottish Enterprise, The University Of Strathclyde and Deepbridge Capital LLP are named as investors in this round.
What does Microplate Dx do?
Microplate Dx Limited specialises in rapid antibiotic susceptibility testing diagnostics, enabling clinicians, at the point-of-care, to confidently select the best choice of antibiotic to treat a patient’s infection in..
Where is Microplate Dx based and how big is it?
Microplate Dx is based in Glasgow, Scotland, United Kingdom.
Who are the decision-makers at Microplate Dx?
Fundz holds 1 contact at Microplate Dx. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Microplate Dx that raised within 45 days of this round, from Fundz verified event records.

  • BrainBox raised $7.1M on October 26, 2023.
  • 3Helix raised $3.7M (Seed) on October 26, 2023.
  • Mustang Bio raised $4.7M (Seed) on October 26, 2023.
  • Triveni Bio raised $92M (Series A) on October 26, 2023.
  • Montinutra raised $2.2M (Seed) on October 26, 2023.
  • Apothekary raised $3.2M (Seed) on October 26, 2023.

Who to call at Microplate Dx, and when

A new round usually means Microplate Dx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Microplate Dx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Microplate Dx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Microplate Dx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Microplate Dx

Location

Tg528/Lgc Centre Office (Tg216)

Glasgow, Scotland, United Kingdom

About

Microplate Dx Limited specialises in rapid antibiotic susceptibility testing diagnostics, enabling clinicians, at the point-of-care, to confidently select the best choice of antibiotic to treat a patient’s infection in a matter of minutes, significantly quicker than the current gold standard technology which takes at least 2 days. Our award-wining, platform diagnostic test helps reduce the major global health threat of antimicrobial resistance and ultimately, saves lives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Microplate Dx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Microplate Dx's next move

See what Strategic adds

Microplate Dx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.